Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has increased
greatly since the early 1990s, being implicated in a rising number of deaths. This paper …

Background Over the past decades gamma-hydroxybutyrate (GHB) has emerged as a
popular drug with high potential of (ab) use due to its euphoric and relaxing effects. An …

Gamma hydroxybutyrate (GHB) is a central nervous system depressant with euphoric and
relaxant effects. Documentation of GHB prevalence and the underreporting of abuse …

Although MDMA (ecstasy) is a relatively safe recreational drug and is currently considered
for therapeutic use for the treatment of posttraumatic stress disorder (PTSD) and alcohol use …

Background: The recreational drug ecstasy (3, 4-methylenedioxymethamphetamine) is
currently used world-wide. Severe (including fatal) health incidents related to ecstasy have …

Background The COVID-19 pandemic has had a major impact on the access and delivery of
healthcare services, posing unprecedented challenges to healthcare staff worldwide …

Background: Misuse of gammahydroxybutrate (GHB) and its prodrugs gammabutyrolactone
(GBL) and 1, 4 butanediol (1, 4-BD) has increased greatly since the early 1990s, particularly …

Abstract Context 3, 4-Methylenedioxymethamphetamine (MDMA) remains one of the most
commonly used recreational drugs in Europe. Monitoring of Emergency Department (ED) …

The use of illicit stimulants continues to pose a significant challenge to different health
sectors. In Australia, four particular stimulants, namely amphetamines and their derivatives …

Background: Methamphetamine intoxication presentations to emergency departments (EDs)
including trauma centres, general EDs and psychiatric emergency services have risen world …